Weight loss drug could reduce heart attack risk by 20%, study finds
GuardianMay 05
Study: Weight Loss Drugs Decrease Heart Attack Risk
story
Image copyright: Mario Tama/Staff/Getty Images News via Getty Images
The Facts
According to a study presented at the European Congress of Obesity, the medication Semaglutide, an ingredient found in the weight loss drugs Ozempic and Wegovy, reduces the risk of heart attacks, strokes, or death due to cardiovascular health by 20%.
After analyzing over 17.6K obese adults from 41 countries who were at least 45 years old, 62% of those who took the drugs Ozempic, Wegovy, and Rybelsus for 20 weeks lost 5% of their body weight, compared to 10% of those who took the placebo.
The Spin
Pro-establishment narrative
Since the breakthrough discovery of statin cholesterol medications in the 1990s, scientists have been trying to find an even better heart disease preventative. Not only has semaglutide helped people lose incredible amounts of weight, but it's now shown to be the missing piece doctors and patients have sought for decades.
Establishment-critical narrative
Obesity, which is what causes poor heart health, is a natural phenomenon with natural remedies, but pharmaceutical companies want to turn it into the next billion-dollar market. Instead of focusing on the underlying causes, such as trauma, poor diets, and lack of exercise, Big Pharma has offered a drug that you must become dependent on if you want to keep the weight off.
